Latest Breaking News On - El cmnd ca1850532047 - Page 1 : comparemela.com

In a series of pre-clinical trials, Clearmind’s drug candidate MEAI significantly reduced body weight, improved fatty liver disease, and normalized insulin sensitivity Tel Aviv,. | January 7, 2023

United statesIsrael generalHebrew universityTel avivJoseph tamSaja baraghithyAdi zuloff shaniMorgan stanleyHebrew university institute for drug researchHebrew university of jerusalemCanadian securities exchangeClearmind medicine incWorld health organizationBoston scientificFrankfurt stock exchangeMetabolism laboratory